F.A. YUSUPOV, A.A. YULDASHEV, G.M. ORMONOVA, M.SH. ABDYKADYROV

Osh State University, Osh, Kyrgyzstan

  Contact details:

Yuldashev A.A. — postgraduate student of the Department of Neurology, Neurosurgery and Psychiatry

Address: 331 Lenin St., Osh, Kyrgyzstan, 723500, tel.: +996559062491, e-mail: akmal.yuldashev.2017@list.ru

The article presents a review of the literature on the syndrome of posterior reversible leukoencephalopathy. The syndrome of posterior reversible leukoencephalopathy is characterized by a spectrum of neurological and radiological features. The factors are reflected which contribute to the syndrome development, clinical manifestations, radiological signs, mechanisms of development, diagnosis, differential diagnosis, treatment, prognosis, course and outcome in this pathology. A clinical case of the development of reversible posterior leukoencephalopathy syndrome in a patient with newly diagnosed HIV infection is presented.

Key words: posterior reversible leukoencephalopathy syndrome, HIV, PRES-syndrome.

REFERENCES

1. Lamy C., Oppenheim C., Mas J.L. Posterior reversible encephalopathy syndrome. Handbook of clinical neurology, 2014, vol. 121, pp. 1687–1701.
2. Fugate J.E., Rabinstein A.A. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. The Lancet Neurology, 2015, vol. 14 (9), pp. 914–925.
3. Skvortsova V.I., Gubskiy L.V., Mel’nikova E.A. Syndrome of posterior reversible encephalopathy. Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova, 2010, vol. 110, no. 5, pp. 104–109 (in Russ.).
4. Bartynski W.S., Boardman J.F. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am. J. Neuroradiol, 2007, vol. 28 (7), pp. 1320–1327. DOI: 10.3174/ajnr.A0549
5. Dobrynina L.A., Kalashnikova L.A., Bakulin I.S., Kremneva E.I., Krotenkova M.V., Shamtieva K.V. Syndrome of posterior reversible encephalopathy in hypocalcemia: description of the observation and analysis of the pathogenetic significance of electrolyte disorders. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2016, vol. 116, no. 7, pp. 70–77 (in Russ.). DOI: 10.17116/jnevro20161167170-77
6. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A. et al. A reversible posterior leukoenceohaly syndrome. N. Engl. J. Med, 1996, vol. 334 (8), pp. 494–500. DOI: 10.1056/NEJM199602223340803
7. Li Y., Gor D., Walicki D., Jenny D., Jones D., Barbour P. et al. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J. Stroke Cerebrovasc. Dis, 2012, vol. 21 (8), pp. 873–882. DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.010
8. Ollivier M., Bertrand A., Clarençon F., Gerber S., Deltour S., Domont F. et al. Neuroimaging features in posterior reversible encephalopathy syndrome: a pictorial review. J. Neurol. Sci, 2017, vol. 15, pp. 188–200. DOI: 10.1016/j.jns.2016.12.007
9. Mueller-Mang C., Mang T., Pirker A., Klein K., Prchla C., Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology, 2009, vol. 51 (6), pp. 373–383. DOI: 10.1007/s00234-009-0504-0
10. Fugate J.E., Claassen D.O., Cloft H.J., Kallmes D.F., Kozak O.S., Rabinstein A.A. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin. Proc, 2010, vol. 85 (5), pp. 427–432. DOI: 10.4065/mcp.2009.0590
11. Bartynski W.S., Boardman J.F. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol, 2007, vol. 28 (7), pp. 1320–1327. DOI: 10.3174/ajnr.A0549
12. Chou S.O., Lai P.H., Yeh L.R. et al. Posterior reversible leukoencephalopathy syndrome: magnetic resonance imaging and diffusionweighted imaging in 12 cases. Kaohsiung J Med Sci., 2004, vol. 20 (8), pp. 381–388.
13. Lee V.H., Wijdicks E.F., Manno E.M., Rabinstein A.A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol, 2008, vol. 65 (2), pp. 205–210. DOI: 10.1001/archneurol. 2007.46
14. Gudkova V.V., Kimel’fel’d E.I., Stakhovskaya L.V. A little known emergency posterior reversible encephalopathy syndrome. Consilium Medicum, 2018, no. 20 (2), pp. 84–89 (in Russ.). DOI: 10.26442/2075-1753_2018.2.84-89
15. Chou M.C., Lai P.H., Yeh L.R. et al. Posterior reversible encephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases. Kaohsiung J Med Sci., 2004, vol. 20 (8), pp. 381–388.
16. Covarrubias D.J., Luetmer P.H., Campeau N.G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol, 2002, vol. 23 (6), pp. 1038–1048.
17. Yoshida K., Yamamoto T., Mory K. et al. Reversible posterior leukoencephalopathy syndrome in a patient with hypertensive encephalopathy: case report. Neurol Med Chir (Tokyo), 2001, vol. 41, pp. 364–369.
18. Schwartz R.B., Jones K.M., Kalina P. et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. AJR, 1992, vol. 159, pp. 379–383.
19. Leroux G., Sellam J., Costedoat-Chalumeau N. et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus, 2008, vol. 17 (2), pp. 139–147.
20. Bogdanov E.I., Khasanov I.A., Mamedov Kh.I., Khasanova D.M. Differential diagnosis of the syndrome of posterior reversible leukoencephalopathy and infarctions in the basin of the posterior cerebral arteries. Prakticheskaya meditsina, 2012, no. 8, pp. 10–12 (in Russ.).
21. Cai X., Raibagkar P., Shleicher S.M. Management of Posterior Reversible Syndrom Induced by Carbizomib in Patient with Multiple Myeloma. J Clin Oncol, 2016. DOI: 10.1200/JCO.2013.49.6166
22. Sergeev A.V., Osipova V.V., Tabeeva G.R., Snopkova E.V. Syndrome of reversible cerebral vasoconstriction. Nevrologicheskiy zhurnal, 2012, no. 3, pp. 4–11 (in Russ.).
23. Mukhi S.V., Lincoln C.M. MRI in the evaluation of acute visual syndromes. Top Magn. Reson Imaging, 2015, vol. 24 (6), pp. 309–324. DOI: 10.1097/RMR.0000000000000070
24. Caputo N.D., Fraser R.M., Abdulkarim J. Posterior reversible encephalopathy syndrome presenting as papilledema. Am. J. Emerg. Med, 2012, vol. 30 (5), pp. 835.e5–7. DOI: 10.1016/j.ajem.2011.03.016
25. Joos Z.P., Adesina O.O., Katz B.J. Posterior ischemic optic neuropathy in the setting of posterior reversible encephalopathy syndrome and hypertensive emergency. J. Neuroophthalmol, 2014, vol. 34 (2), pp. 151–152. DOI: 10.1097/WNO.0000000000000108
26. Siebert E., Bohner G., Liebig T., Endres M., Liman T.G. Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J. Neurol, 2017, vol. 264 (2), pp. 237–242. DOI: 10.1007/s00415-016-8328-4
27. Schusse C.M., Peterson A.L., Caplan L.P. Posterior reversible encephalopathy syndrome. Psychosomatics, 2013, vol. 54 (3), pp. 205–211. DOI: 10.1016/j.psym.2013.01.014
28. Tikhomirov G.V., Grigor’eva V.N. Posterior reversible leukoencephalopathy syndrome: a clinical case and literature review. Doktor. Ru, 2019, no. 1 (156), pp. 25–31 (in Russ.).
29. Hobson E.V., Craven I., Blank S.C. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Peritoneal dialysis international journal of the International Society for Peritoneal Dialysis, 2012, Nov-Dec. PubMed PMID: 23212858.
30. Strother R., Wong H., Miller N.E. Posterior Reversible Encephalopathy Syndrome Secondary to Hypertensive Encephalopathy Brought on by a MAO Inhibitor: A Case Report. Journal of primary care & community health, 2019, Jan-Dec. PubMed PMID: 31423884.
31. Vandenbossche G., Maquet J., Vroonen P., Lambert G., Nisolle M., Kridelka F., Emonts E. A reversible posterior leucoencephalopathy syndrome including blindness caused by preeclampsia. Facts, views. PubMed PMID: 28003872.
32. Karpati G., Carpenter S., Wolfe L.S., Karpati G., Carpenter S., Wolfe L.S. Juvenile dystonic lipidosis: an unusual form of neurovisceral storage disease. Neurology, 1977, Jan. PubMed PMID: 29279639.
33. Whitaker J.N., Hashimoto K., Quinones M. Skeletal muscle pseudo hypertrophy in primary amyloidosis. Neurology, 1977, Jan. PubMed PMID: 26633947.
34. Lifson N., Pasquale A., Salloum G., Alpert S. Ophthalmic Manifestations of Posterior Reversible Encephalopathy Syndrome. Neuro-ophthalmology (Aeolus Press), 2019, Jun. PubMed PMID: 31312242.
35. Zou L.P., Liu L.Y., Li H., Wang Y.Y., Liu Y., Chen J., Hu L.Y., Liu M.J., Zhang M.N., Lu Q., Ma S.F. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale. BMC neurology, 2019, Feb 21. PubMed PMID: 30791893.